Update on Juvenile Spondyloarthritis

被引:25
|
作者
Ramanathan, Anusha [1 ]
Srinivasalu, Hemalatha [2 ]
Colbert, Robert A. [3 ]
机构
[1] Childrens Hosp Los Angeles, Keck Sch Med USC, Div Rheumatol, Los Angeles, CA 90027 USA
[2] George Washington Univ, Childrens Natl Med Ctr, Div Rheumatol, Washington, DC 20010 USA
[3] Natl Inst Arthrit Musculoskeletal & Skin Dis NIAM, Pediat Translat Res Branch, NIH, Bethesda, MD 20892 USA
关键词
Juvenile spondyloarthritis; Enthesitis-related arthritis; Juvenile psoriatic arthritis; HLA-B27; Axial spondyloarthritis; ENTHESITIS-RELATED ARTHRITIS; ACTIVE ANKYLOSING-SPONDYLITIS; DISTAL INTERPHALANGEAL JOINT; ANTITUMOR NECROSIS FACTOR; SOCIETY CLASSIFICATION CRITERIA; MAJOR CLINICAL-RESPONSE; IDIOPATHIC ARTHRITIS; PSORIATIC-ARTHRITIS; RADIOGRAPHIC PROGRESSION; AXIAL SPONDYLOARTHRITIS;
D O I
10.1016/j.rdc.2013.06.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Spondyloarthritis (SpA) encompasses a group of disorders linked by overlapping clinical manifestations and genetic predisposition. Newer classification systems developed for adults with SpA focus on identifying individuals with axial or predominantly peripheral involvement. All forms of SpA can begin during childhood, and can be considered on a continuum with adult disease. Nevertheless, there are important differences in presentation and outcome that depend on age at onset. This article highlights these differences, what has been learned about genetics and pathogenesis of SpA, and important unmet needs for future studies.
引用
收藏
页码:767 / +
页数:23
相关论文
共 50 条
  • [41] Juvenile dermatomyositis update
    Lindsley C.B.
    Current Rheumatology Reports, 2006, 8 (3) : 174 - 177
  • [42] An update on juvenile dermatomyositis
    Boccaletti, V.
    Di Nuzzo, S.
    Feliciani, C.
    Fabrizi, G.
    Pagliarello, C.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2014, 149 (05): : 519 - 524
  • [43] Juvenile justice: An update
    Ratner, RA
    ADOLESCENT PSYCHIATRY, VOL 24, 1999, 24 : 143 - 158
  • [44] Treatment of Juvenile Spondyloarthritis: Where We Stand
    John M. Bridges
    Matthew L. Stoll
    Pediatric Drugs, 2020, 22 : 603 - 615
  • [45] Recognition and treatment of juvenile-onset spondyloarthritis
    Gensler, Lianne
    Davis, John C., Jr.
    CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (05) : 507 - 511
  • [46] Treatment of Juvenile Spondyloarthritis: Where We Stand
    Bridges, John M.
    Stoll, Matthew L.
    PEDIATRIC DRUGS, 2020, 22 (06) : 603 - 615
  • [47] ENTHESITIS-RELATED ARTHRITIS: IS IT JUVENILE SPONDYLOARTHRITIS?
    Colbert, R. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 605 - 605
  • [48] Is There a Need for a New Classification Criteria in Juvenile Spondyloarthritis?
    Martha Katsicas, Maria
    Cecilia Bertinotti, Maria
    Giselle Villarreal, Maria
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 508 - 509
  • [49] Sacroiliitis at Diagnosis in Children with Juvenile Spondyloarthritis.
    Weiss, Pamela
    Xiao, Rui
    Chauvin, Nancy
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S834 - S834
  • [50] Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies
    Marino, Achille
    De Souza, Mirian
    Giani, Teresa
    Cimaz, Rolando
    EXPERT OPINION ON PHARMACOTHERAPY, 2020, 21 (17) : 2161 - 2168